在癌细胞静止中NuRD复合体和改变蛋白质稳定性的作用
Qi Jiang1,2, Michelle Ertel3, Austin Arrigo1
1Obstetrics and Gynecology Magee-Womens Research Inst. & Foundation, Pittsburgh, PA, USA.
bioRxiv : the preprint server for biology
|February 24, 2025
概括
静止,细胞周期的退出状态,驱动卵巢癌 (OvCa) 的化学抵抗. 用HDAC抑制剂向NuRD复合体可以诱导静止,并使OvCa细胞对组合疗法敏感.
科学领域:
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
- 分子生物学分子生物学
背景情况:
- 细胞毒性化疗是卵巢癌 (OvCa) 的标准治疗方法,但化学抵抗导致患者的治疗结果不佳.
- 化学抵抗机制对于理解至关重要,细胞静止是一个尚未探索的因素.
- 静止细胞退出细胞周期,并且对针对快速分裂细胞的疗法具有抗性.
研究的目的:
- 调查核细胞重塑和脱乙酶 (NuRD) 复合体在卵巢癌细胞静止中的作用.
- 通过了解卵巢癌中化学抵抗的分子基础来确定新的治疗策略.
主要方法:
- 在静止的OvCa细胞 (qOvCa) 中分析了CHD4和MBD3,NuRD复杂组件的下调.
- 使用CHD4/MBD3倒置和基因素脱乙酶抑制剂 (HDACi),如沃里诺斯塔特,以诱导OvCa细胞的静止.
- 进行RNA测序 (RNA-Seq) 来确认与静止相关的基因表达变化.
- 在qOvCa和HDACi处理的细胞中评估了蛋白质稳定性改变 (蛋白质酶活性,自).
- 评估了涉及HDACi与蛋白酶体或自抑制剂的组合疗法.
- 通过将OvCa静止特征与酵母静止基因进行比较,确定了一种保存的"静止细胞核心特征".
主要成果:
- 在静止的OvCa细胞中,CHD4和MBD3的下调.
- 对CHD4/MBD3的抑制或对HDACi (vorinostat) 的治疗成功诱导了OvCa细胞的静止状态.
- RNA-Seq证实,HDACi治疗诱导了与静止相一致的基因表达变化.
- 静止的OvCa细胞表现出改变的蛋白质稳定,包括增加的蛋白质酶活性和自.
- 使用HDACi与蛋白酶体或自抑制剂的联合治疗导致了协同作用的癌细胞死亡.
- 在不同癌症类型中发现了一种保存的"静止细胞核心签名".
结论:
- NuRD复杂降低调节与诱导卵巢癌细胞静止有关.
- HDAC 抑制剂可以诱导静止,并使卵巢癌细胞对向蛋白质稳定性的组合疗法敏感.
- 鉴定到的"静止细胞核心签名"表明,对多种癌症类型的治疗标可以保留.
相关概念视频
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
Negative Regulator Molecules
35.1K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.1K
The Nucleolus
8.6K
The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
8.6K
Inhibition of Cdk Activity
4.6K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.6K
Loss of Tumor Suppressor Gene Functions
4.7K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
4.7K


